Skip to content
Research Article Open access CC BY 4.0

Metformin Toxicity in Chronic Kidney Disease: A Case Report of Severe Lactic Acidosis

Aalia P.S, Farisa T.A, Lakshmi R, Binu Upendran, Punnose Thomas

International Journal of Medical and Pharmaceutical Case Reports · pp. 47–51 · Published 14 Feb 2025

10.9734/ijmpcr/2025/v18i1413

Abstract

Metformin is one of the most commonly prescribed oral antihyperglycemic medicine worldwide. Professional diabetes organizations recommend it as the first-line treatment for newly diagnosed type 2 diabetes. Metformin is widely regarded as safe. The most common side effects include nausea, vomiting and diarrhea. Metformin-associated lactic acidosis (MALA) is a rare but serious adverse effect of metformin. Here, we are reporting a case of an elderly patient hospitalized with severe lactic acidosis presented with complaints of hypotension, decreased food intake, multiple episodes vomiting, dyspnoea, related to the treatment of type 2 diabetes with metformin. The patient was treated with emergency dialysis, vasopressor therapy and Inj Sodium bicarbonate.

MALA type 2 diabetes mellitus metformin lactic acidosis chronic kidney disease renal dialysis

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.